Prediction and reversion of post-transplant relapse in patients with chronic myeloid leukemia using mixed chimerism and residual disease detection and adoptive immunotherapyFORMANKOVA, R; HONZATKOVA, L; MORAVCOVA, J et al.Leukemia research. 2000, Vol 24, Num 4, pp 339-347, issn 0145-2126Article

Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulinSEDLACEK, P; FORMANKOVA, R; KESLOVA, P et al.Bone marrow transplantation (Basingstoke). 2006, Vol 38, Num 11, pp 745-750, issn 0268-3369, 6 p.Article

Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemiaFORMANKOVA, R; HONZATKOVA, L; SIEGLOVA, Z et al.Bone marrow transplantation (Basingstoke). 2000, Vol 25, Num 4, pp 453-456, issn 0268-3369Article

B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALLFRONKOVA, E; MUZIKOVA, K; MEJSTRIKOVA, E et al.Bone marrow transplantation (Basingstoke). 2008, Vol 42, Num 3, pp 187-196, issn 0268-3369, 10 p.Article

Allo-SCT in children with high-risk leukemia using unmanipulated grafts from alternative donorsSEDLACEK, P; MEJSTRIKOVA, E; FORMANKOVA, R et al.Bone marrow transplantation. Supplement (Basingstoke). 2008, Vol 42, Num 2, issn 0951-3078, S10-S15Conference Paper